Teva Pharmaceutical on Thursday announced the launch of generic Baraclude (entecavir) tablets in 0.5-mg and 1-mg dosage strengths. The company was the first to file, giving it 180 days of marketing exclusivity for the drug.
PharmaSmart on Wednesday announced the debut of its next generation biometric kiosk, the Model PS2000 (D)estination, which recently completed a pilot inside Mariano’s, a grocer with 26 stores located in the Chicagoland Metro area.
Abbott on Wednesday announced that it has received CE Mark (Conformite Europeenne) for its FreeStyle Libre Flash Glucose Monitoring System, a revolutionary new glucose-sensing technology for people with diabetes.
GlaxoSmithKline announced that the Food and Drug Administration approved its supplemental new drug application for Promacta (eltrombopag), a once-daily medication for patients with severe aplastic anaemia who have had an insufficient response to immunosuppressive therapy.